News
February 2012
Now Jun |
May |
Apr |
Mar |
Feb |
Jan 2011: Dec |
Nov |
Oct |
Sep |
Aug |
July
Search
2010 |
2009 |
2008 |
2007 |
2006 |
2005
BioCity Scotland signs up first
business partner
BioCity Scotland, the newly-opened life
sciences cluster in Newhouse, Lanarkshire, has signed a three-year
agreement with leading patent attorneys HGF making them the first
corporate partner to join the BioCity team. 29 Feb 2012
Cellnovo launches
mobile-connected diabetes management system
The system
comprises an insulin pump that connects wirelessly to an intuitive
'app-based' touch-screen handset with integral blood glucose
monitor, an activity monitor and a mobile (GSM) data connection to a
web-based clinical management system. 29 Feb 2012
Automated blood culture systems
deployed to NATO field hospital in Afghanistan
The UK
Ministry of Defence has purchased three bioMérieux BacT/ALERT 3D 60
automated blood culture systems for the Camp Bastion Field Hospital
in Afghanistan. 29 Feb 2012
Clinical studies show Boston Scientific WallFlex enteral stents safe
and effective
Boston Scientific Corporation has announced that
it welcomes positive results from three studies of its WallFlex enteral
stent systems, a family of self-expanding metal stents (SEMS) used to
alleviate obstructive symptoms caused by cancers of the gastrointestinal
tract. 29 Feb 2012
Integromics partners
with FPGMX to develop low-cost methods for clinical genomics
Integromics has entered into a partnership with the Galician
Foundation of Genomic Medicine for the development of inexpensive
solutions for clinical genomics. 29 Feb 2012
RainDance and Sony DADC develop
manufacturing capacity for DNA sequencing consumables
RainDance Technologies, Inc. and Sony DADC Austria AG, have further
developed proprietary methods for the manufacture of microdroplet-based
smart consumables for high-throughput targeted DNA sequencing
applications. 29 February 2012
Wireless self-propelled chip swims
through blood vessels
A tiny, wirelessly powered,
self-propelled medical device capable of controlled motion through
blood vessels has been developed by electrical engineers at Stanford
University. 28 Feb 2012
Commonly prescribed sleeping pills
linked to fourfold increased risk of death
A study of over
30,000 patients has found that a number of commonly prescribed
sleeping pills are associated with a more than fourfold increased
risk of death even at low doses. 28 Feb 2012
First implantable wireless
programmable microchip for controlling drug delivery
MicroCHIPS, Inc. has published the results of the first successful
human clinical trial with an implantable, wirelessly controlled and
programmable microchip-based drug delivery device. 24 Feb 2012
Boston Scientific
launches endoscopic ultrasound aspiration needle worldwide
The Expect 19 Flex endoscopic ultrasound aspiration needle is used
for acquiring tissue samples under endoscopic ultrasound (EUS)
guidance for cancer diagnosis in organs adjacent to the
gastrointestinal tract. 24 Feb 2012
Laser-heated carbon
nanotubes kill breast cancer stem cells
Researchers at Wake
Forest Baptist Medical Center in the US have shown that injecting
multiwalled carbon nanotubes (MWCNTs) into tumours and heating them
with a 30-second laser treatment can kill them. 24 Feb 2012
Endomagnetics wins ACES award for
most successful university spinout
Endomagnetics is
developing advanced magnetic sensing technology for use in breast
cancer staging, based on technology developed between University
College London and at the University of Houston. 23 Feb 2012
Southampton and Oxford chemists to
develop cheaper DNA building system
The scientists hope that
their research could enable the production of useful DNA and RNA
molecular structures more efficiently and on a larger scale than is
possible using current enzyme-based technologies. 23 Feb 2012
Light against Cancer raises awareness
of photodynamic therapy to treat tumours
The German
organisation Light against Cancer is raising awareness of
Photodynamic Therapy (PDT) as a new therapeutic approach for
treating cancer without the side effects of chemotherapy or
radiotherapy. 23 Feb 2012
LGC Standards announces
ATCC SDO release of ground-breaking standards for human cell lines
The ATCC Standards Development Organization, has published its
second voluntary consensus standard, ASN-0002: Authentication of
Human Cell Lines: Standardization of STR Profiling. 23 Feb 2012
New thyroid uptake system from Southern Scientific
The Capintec Captus 700t has a new colour touchscreen that simplifies and speeds-up thyroid uptake, wipe,
bio-assay, blood volume and RBC survival tests. 23 Feb 2012
UCB and Cyclofluidic announce
success for new drug discovery platform
Scientists at
Cyclofluidic are currently developing a technology platform called
the Cyclofluidic Integrated Discovery Platform (CIDP) and have used
this proprietary technology to design, make and screen potential
drug molecules against selected targets. 22 Feb 2012
Expert panel highlights
dangers of unregulated use of nanomaterials in consumer products
The panel, convened by the National Research Council (NRC),
published a report that concluded that despite the surge of
nanomaterials in the marketplace, not enough is known about their
potential health and environmental risks. 22 Feb 2012
EOS Imagine raises over €38m on NYSE
NBGI Ventures has announced that its portfolio company EOS Imagine,
has raised over €38 million in a successful public offering of
shares on the NYSE Euronext. 20 Feb 2012
PneumaScan installed in
Hospital Kuala Lumpur
Cambridge company PneumaCare Limited
has installed its innovative PneumaScan respiratory assessment
device in Hospital Kuala Lumpur. 20 Feb 2012
UCL spinout takes nano-enabled pain
therapy to international markets
Support by the UK NanoKTN
has helped UCL School of Pharmacy spin-out Nanomerics to take its
patented nano-enabled therapeutic technology to international
markets. 20 Feb 2012
NHS interest in financing techniques
to purchase medical equipment soars
New research from
Siemens Financial Services (SFS) has revealed steeply rising
interest in leasing in the NHS. The research tracked the number and
the value of leasing tenders issued by the NHS. 20 Feb 2012
Discovery of peptides in flu virus
opens door to universal flu vaccine
The discovery of a
series of peptides, on the internal structures of influenza viruses
could lead to the development of a universal vaccine for all strains
of influenza. 20 Feb 2012
Lack of evidence of safety of cold
water baths in sport
Top athletes and sports people commonly
use cold water baths after exercise to reduce muscle soreness, but
it is unclear whether there are harmful side effects or that this is
better than other methods. 15 Feb 2012
Phosphate additives in
food cause artery damage and premature
aging
There is increasing evidence that an elevated level of phosphate in
the blood not only promotes calcification of blood vessels and
bodily organs but also upsets a complex hormonal system involved in
regulation of phosphate in the body. 15 Feb 2012
European neurodegenerative disease
research strategy launched
The EU Joint Programme in
Neurodegenerative Disease Research (JPND) is the first of the
European Joint Programming initiatives which are designed to address
the ‘grand challenges’ facing EU society. 9 Feb 2012
Boston Scientific
launches crossing device to treat blockages in peripheral arteries
Boston Scientific has launched in the USA the TruePath CTO Device,
designed to facilitate the crossing of chronic total occlusions
within the peripheral vasculature. 9 Feb 2012
Sanofi: 2011 Results Benefit from Genzyme Acquisition. 8
Feb 2012
Syngenta CEO Announces Record Free Cashflow at Full-Year Results.
8 Feb 2012
Gerresheimer Achieves High Growth in the 2011 Financial Year.
8 Feb 2012
Siemens Forms New Companion Diagnostics Partnerships with ViiV
Healthcare and Tocagen. 8 Feb 2012
Pepscan Therapeutics Achieves Milestones in Research Collaboration
With Janssen R&D Ireland. 8 Feb 2012
Maquet launches 3D HD surgical
camera
Maquet has launched Orchide 3D, a medical grade 3D
high definition video camera. This camera sets a new standard of
image quality in surgery, with the ability to distinguish depth in
the screen as well as in a body cavity. 6 Feb 2012
Southern Scientific moves to Henfield
The move follows the purchase of Southern Scientific in
September 2011 by LabLogic Systems. 6 Feb 2012
GE healthymagination Fund invests in
Check-Cap's ingestible imaging capsule
GE Financial Services
has announced that it has invested in Israeli company Check-Cap Ltd,
a developer of an ingestible X-ray imaging capsule that may help
detect intestinal polyps and colorectal cancer. 6 Feb 2012
Targeted nanoparticles deliver diabetes drugs directly to pancreas
Lab studies have shown
that nanoparticles containing protein molecules that bind to
pancreas cells can effectively deliver diabetes drugs directly to
the pancreas, the organ that produces insulin and is at most risk
during onset of diabetes.
World's first designer jaw built from titanium using additive
manufacturing
Belgian company LayerWise has built a total
lower jaw implant from titanium using its additive manufacturing (AM)
system. The jaw was built to treat a senior patient’s progressive
osteomyelitis of almost the entire lower jawbone. 3 Feb 2012
AstraZeneca announces 2,200 R&D job
cuts worldwide
AstraZeneca has announced a set of new
restructuring initiatives along with its full-year 2011 results
today. The programme is expected to lead to 7,300 job losses in
total, with 2,200 of those R&D and save $1.6bn annually. 2 Feb 2012
Influenza virus diagnosed in record
time with new genetic test
The test, developed by researchers
at the RIKEN Omics Science Center can detect influenza virus
infection in 40 minutes and with one hundred times the sensitivity
of conventional methods. 2 Feb 2012
Liverpool universities and hospitals
to build 2 million sq ft BioInnovation Centre
The Liverpool
BioInnovation Centre is a 2 million square foot project that aims to
create up to 5000 high tech jobs and make Liverpool a world class
centre of innovation in the life sciences. 2 Feb 2012
BD Max benchtop rapid
MRSA assay test launched in Europe
BD MAX is a bench-top
molecular system designed to perform a broad range of molecular
testing. 2 Feb 2012
Search
2012
Jan |
Feb |
Mar |
Apr |
May |
Jun | now
2011
Jan |
Feb |
Mar |
Apr |
May |
Jun | Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2010
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2009
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2008
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2007
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2006
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec
2005
Jan |
Feb |
Mar |
Apr |
May |
Jun |
Jul |
Aug |
Sep |
Oct |
Nov |
Dec